GLPCX | SPNNX | GLPCX / SPNNX | |
Total Expense Ratio | 7.74 | 9.27 | 83% |
Annual Report Gross Expense Ratio | 7.74 | 9.27 | 83% |
Fund Existence | 12 years | 6 years | - |
Gain YTD | 2.028 | 4.647 | 44% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.62B | 3.91B | 41% |
Annual Yield % from dividends | 8.31 | 7.41 | 112% |
Returns for 1 year | 9.17 | 12.01 | 76% |
Returns for 3 years | 57.53 | 63.59 | 90% |
Returns for 5 years | 201.19 | 243.35 | 83% |
Returns for 10 years | 41.12 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 80.75 | 0.71 | +0.89% |
T. Rowe Price Health Sciences | |||
RSVAX | 25.66 | 0.06 | +0.23% |
Victory RS Value A | |||
HWSCX | 56.54 | 0.09 | +0.16% |
Hotchkis & Wiley Small Cap Value C | |||
RSDFX | 41.21 | -0.06 | -0.15% |
Columbia Dividend Opportunity Inst2 | |||
BCVCX | 32.27 | -0.15 | -0.46% |
Sterling Capital Behav Lg Cp Val Eq C |